DK170279B1 - 3-substituerede l-aminoalkyl-lH-indol-forbindelser, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse - Google Patents

3-substituerede l-aminoalkyl-lH-indol-forbindelser, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse Download PDF

Info

Publication number
DK170279B1
DK170279B1 DK354485A DK354485A DK170279B1 DK 170279 B1 DK170279 B1 DK 170279B1 DK 354485 A DK354485 A DK 354485A DK 354485 A DK354485 A DK 354485A DK 170279 B1 DK170279 B1 DK 170279B1
Authority
DK
Denmark
Prior art keywords
compound
indole
methyl
morpholinyl
amino
Prior art date
Application number
DK354485A
Other languages
Danish (da)
English (en)
Other versions
DK354485A (da
DK354485D0 (da
Inventor
Malcolm Rice Bell
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of DK354485D0 publication Critical patent/DK354485D0/da
Publication of DK354485A publication Critical patent/DK354485A/da
Application granted granted Critical
Publication of DK170279B1 publication Critical patent/DK170279B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
DK354485A 1984-08-06 1985-08-05 3-substituerede l-aminoalkyl-lH-indol-forbindelser, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse DK170279B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63793184A 1984-08-06 1984-08-06
US63793184 1984-08-06

Publications (3)

Publication Number Publication Date
DK354485D0 DK354485D0 (da) 1985-08-05
DK354485A DK354485A (da) 1986-02-07
DK170279B1 true DK170279B1 (da) 1995-07-24

Family

ID=24557949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK354485A DK170279B1 (da) 1984-08-06 1985-08-05 3-substituerede l-aminoalkyl-lH-indol-forbindelser, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse

Country Status (20)

Country Link
EP (1) EP0171037B1 (no)
JP (1) JPH0670010B2 (no)
KR (1) KR870000548B1 (no)
AR (1) AR244665A1 (no)
AT (1) ATE77371T1 (no)
AU (1) AU574817B2 (no)
DE (1) DE3586224T2 (no)
DK (1) DK170279B1 (no)
ES (5) ES8609246A1 (no)
FI (1) FI852973L (no)
GR (1) GR851937B (no)
IE (1) IE57863B1 (no)
IL (1) IL75966A (no)
MX (4) MX160612A (no)
MY (1) MY101186A (no)
NO (1) NO169067C (no)
NZ (3) NZ225467A (no)
PH (2) PH23498A (no)
PT (1) PT80919B (no)
ZA (1) ZA855923B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
US4840950A (en) * 1987-02-11 1989-06-20 Sterling Drug Inc. 4-arylcarbonyl-1-[(4-morpholinyl)-lower-alkyl]-1H-indoles
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
US5312829A (en) * 1990-05-21 1994-05-17 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
TW270114B (no) * 1993-10-22 1996-02-11 Hoffmann La Roche
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
KR20020035857A (ko) 1999-08-26 2002-05-15 후지야마 아키라 인돌 유도체 또는 그의 염의 제조방법
JP6493786B2 (ja) * 2015-01-06 2019-04-03 パナソニックIpマネジメント株式会社 免疫原、それを用いた抗体の製造方法、及び、そのモノクローナル抗体
JP6435505B2 (ja) * 2015-01-13 2018-12-12 パナソニックIpマネジメント株式会社 化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238215A (en) * 1963-10-17 1966-03-01 Sterling Drug Inc 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US3217011A (en) * 1965-05-07 1965-11-09 Sterling Drug Inc 1-(indolyglyoxalyl)-piperidines
US3487091A (en) * 1967-12-18 1969-12-30 American Home Prod 1-(benzyl- or substituted-benzyl)-3-(2-substituted-ethyl) indoles
GB1374414A (en) * 1972-06-12 1974-11-20 Sterling Drug Inc 1-acyl-3-amino-alkyl-indoles and their preparation
GB1436771A (en) * 1973-02-16 1976-05-26 Labaz Indole derivatives and process for preparing the same
FR2354766A1 (fr) * 1976-06-17 1978-01-13 Labaz Derives n-aminoalkyles d'indole et procedes pour les preparer
ZW1585A1 (en) * 1984-02-07 1985-06-19 Pfizer 1,3-disubstituted oxindoles as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
MX14429A (es) 1993-09-01
PH23498A (en) 1989-08-16
ES8800901A1 (es) 1987-12-01
AU4576485A (en) 1986-02-13
NZ225466A (en) 1990-02-26
ES8801203A1 (es) 1987-12-16
NO169067B (no) 1992-01-27
MY101186A (en) 1991-07-31
DE3586224T2 (de) 1993-01-28
ES552910A0 (es) 1987-12-16
AU574817B2 (en) 1988-07-14
ES8609246A1 (es) 1986-07-16
DE3586224D1 (de) 1992-07-23
ES545894A0 (es) 1986-07-16
MX14432A (es) 1993-08-01
IL75966A (en) 1989-08-15
DK354485A (da) 1986-02-07
FI852973L (fi) 1986-02-07
JPH0670010B2 (ja) 1994-09-07
AR244665A1 (es) 1993-11-30
ZA855923B (en) 1986-03-26
KR860001805A (ko) 1986-03-22
ES552909A0 (es) 1987-12-01
ES552912A0 (es) 1987-10-16
FI852973A0 (fi) 1985-08-01
MX14431A (es) 1993-08-01
EP0171037A2 (en) 1986-02-12
KR870000548B1 (ko) 1987-03-18
GR851937B (no) 1985-12-05
JPS6147463A (ja) 1986-03-07
PT80919A (en) 1985-09-01
IE851930L (en) 1986-02-06
ES8800902A1 (es) 1987-12-01
ATE77371T1 (de) 1992-07-15
PH25360A (en) 1991-05-13
IE57863B1 (en) 1993-05-05
NZ212953A (en) 1990-02-26
DK354485D0 (da) 1985-08-05
MX160612A (es) 1990-03-28
EP0171037A3 (en) 1987-08-26
ES8800149A1 (es) 1987-10-16
IL75966A0 (en) 1985-12-31
EP0171037B1 (en) 1992-06-17
NO169067C (no) 1992-05-06
NZ225467A (en) 1990-02-26
NO853066L (no) 1986-02-07
PT80919B (pt) 1987-09-30
ES552911A0 (es) 1987-12-01

Similar Documents

Publication Publication Date Title
US5817651A (en) 3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles
US4885295A (en) Method of use of 3-arylcarbonyl- and 3-cycloalkyl-carbonyl-1-aminoalkyl-1H-indoles
AU677644B2 (en) Piperazine derivatives
US4695578A (en) 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
IE57809B1 (en) 1,2,3,9-tetrahydro-3-(imidazol-1-ylmethyl)-4h-carbazol-4 one derivatives
CZ283018B6 (cs) Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
MXPA04010076A (es) Nuevos derivados de pirrolidinio.
DK170279B1 (da) 3-substituerede l-aminoalkyl-lH-indol-forbindelser, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse
CA1246563A (en) 3-arylcarbonyl- and 3-cycloalkylcarbonyl-1-aminoalkyl- 1h-indoles useful as analgesics
JPS63146874A (ja) インドール誘導体
JP3157179B2 (ja) 3−アリールカルボニル−1−アミノアルキル−1h−インドール含有抗緑内障組成物
US4978664A (en) 3-arylcarbonyl- and 3-cycloalkyl-carbonyl-1-aminoalkyl-1H-indole pharmaceutical compositions
US5013732A (en) 3-arylcarbonyl- and 3-cycloalkyl-carbonyl-1-aminoalkyl-1H-indoles
CZ410391A3 (en) Novel cyclic amine derivatives, medicaments in which said derivatives are comprised and process for preparing thereof
EA026782B1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛИЛБЕНЗО[d]ИМИДАЗОЛА
CA2118375A1 (en) Cyclic amine derivatives
US4634776A (en) 3-arylcarbonyl-and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles
US5770611A (en) Indole derivatives as 5HT1 -like agonists
AU707750B2 (en) Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
CA1255316A (en) 3-arylcarbonyl-1h-indoles useful as anti-rheumatic agents as well as intermediates and their production process
USRE32761E (en) 3-arylcarbonyl and 3-cycloalkylcarbonyl-1-aminoalkyl-1H-indoles, compositions and use
JPH0525140A (ja) ベンズイミダゾール誘導体
WO1995021166A1 (en) Triazole derivatives
JPS61210083A (ja) 複素環式化合物

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK